Agnoprotein of mammalian polyomaviruses

Virology

Volumn 432, Issue 2, 2012, Pages 316-326

  Gerits, Nancy ^a   Moens, Ugo ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Agnoprotein; Interaction partner; Mutation; Post translational modification; Subcellular localization; Viroporin

Indexed keywords

AGNOPROTEIN; CARRIER PROTEIN; FASCICULATION AND ELONGATION PROTEIN ZETA 1; HETEROCHROMATIN PROTEIN 1; HETEROCHROMATIN PROTEIN 1ALPHA; KU ANTIGEN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS LARGE T ANTIGEN; VIRUS SMALL T ANTIGEN; Y BOX BINDING PROTEIN 1;

AMINO ACID SEQUENCE; ARTICLE; CARCINOGENICITY; CELLULAR DISTRIBUTION; DNA REPLICATION; GENE EXPRESSION REGULATION; MAMMAL; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYOMA VIRUS; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN STRUCTURE; VIROGENESIS; VIRUS INTERFERENCE; VIRUS RELEASE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; CARNIVORA; HUMANS; MOLECULAR SEQUENCE DATA; POLYOMAVIRIDAE; PRIMATES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RODENTIA; SUBCELLULAR FRACTIONS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

AVES; MAMMALIA; MIRIDAE; POLYOMAVIRIDAE; POLYOMAVIRUS;

EID: 84865283042     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.05.024     Document Type: Article

References (117)

1. Abend J.R., Joseph A.E., Das D., Campbell-Cecen D.B., Imperiale M.J. A truncated T antigen expressed from an alternatively spliced BK virus early mRNA. J. Gen. Virol. 2009, 90:1238-1245.
2. Akan I., Sariyer I.K., Biffi R., Palermo V., Woolridge S., White M.K., Amini S., Khalili K., Safak M. Human polyomavirus JCV late leader peptide region contains important regulatory elements. Virology 2006, 349:66-78.
3. Allander T., Andreasson K., Gupta S., Bjerkner A., Bogdanovic G. Identification of a third human polyomavirus. J. Virol. 2007, 81:4130-4136.
4. Barkan A., Mertz J.E. DNA sequence analysis of simian virus 40 mutants with deletions mapping the late viral mRNA's: mutants with deletions similar in size and position exhibit varied phenotypes. J. Virol. 1981, 37:730-737.
5. Barkan A., Welch R.C., Mertz J.E. Missense mutations in the VP1 gene of simian virus 40 that compensate for defects caused by deletions in the viral agnogene. J. Virol. 1987, 61:3190-3198.
6. Bjellqvist B., Basse B., Olsen E., Celis J.E. Reference points for comparisons of two-dimensional maps of proteins from different human cell types defined in a pH scale where isoelectric points correlate with polypeptide compositions. Electrophoresis 1994, 15:529-539.
7. Bollag B., Hofsetter C.A., Reviriego-Mendoza M.M., Frisque R.J. JC virus small T antigen binds phosphatase PP2A and Rb family proteins and is required for efficient viral DNA replication activity. PLoS One 2010, 5:e10606.
8. Brew B.J., Davies N.W., Cinque P., Clifford D.B., Nath A. Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nat. Rev. Neurol. 2010, 6:667-679.
9. Brown D.A. Lipid droplets: proteins floating on a pool of fat. Curr. Biol. 2001, 11:R446-R449.
10. Cantalupo P., Doering A., Sullivan C.S., Pal A., Peden K.W., Lewis A.M., Pipas J.M. Complete nucleotide sequence of polyomavirus SA12. J. Virol. 2005, 79:13094-13104.
11. Carswell S., Alwine J.C. Simina virus 40 agnoprotein facilitates perinuclear-nuclear localization of VP1, the major capsid protein. J. Virol. 1986, 60:1055-1061.
12. Carswell S., Resnick J., Alwine J.C. Construction and characterization of CV-1P cell lines which constitutively express the simian virus 40 agnoprotein: alteration of plaquing phenotype of viral agnogene mutants. J. Virol. 1986, 60:415-422.
13. Chen Y., Sharpt P.M., Fowkes M., Kocher O., Joseph J.T., Koralnik I.J. Analysis of 15 novel full-length BK virus sequences from three individuals: evidence of a high intra-strain genetic diversity. J. Gen. Virol. 2004, 85:2651-2663.
14. Chenna R., Sugawara H., Koike T., Lopez R., Gibson T.J., Higgins D.G., Thompson JD. Multiple sequence alignment with the Clustal series of programs. Nucl. Acids Res. 2003, 31:3497-3500.
15. Colegrove K.M., Wellehan J.F., Rivera R., Moore P.F., Gulland F.M., Lowenstine L.J., Nordhausen R.W., Nollens H.H. Polyomavirus infection in a free-ranging California sea lion (Zalophus californianus) with intestinal T-cell lymphoma. J. Vet. Diagn. Invest. 2010, 22:628-632.
16. Darbinyan A., Darbinian N., Safak M., Radhakrishnan S., Giordano A., Khalili K. Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene 2002, 21:5574-5581.
17. Darbinyan A., Siddiqui K.M., Slonina D., Darbinian N., Amini S., White M.K., Khalili K. Role of JC virus agnoprotein in DNA repair. J. Virol. 2004, 78:8593-8600.
18. Darbinyan A., White M.K., Akan S., Radhakrishnan S., del Valle L., Amini S., Khalili K. Alternations of DNA damage repair pathways resulting from JCV infection. Virology 2007, 364:73-86.
19. Davies S.P., Reddy H., Calvano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 2000, 351:95-105.
20. Delmas V., de La Roche Saint Andre C., Gardes M., Goutebroze L., Feunteun J. Early gene expression in lymphoma-associated hamster polyomavirus viral genomes. Oncogene 1992, 7:295-302.
21. Del Valle L., Khalili K. Detection of human polyomavirus proteins, T-antigen and agnoprotein in human tumor tissue arrays. J. Med. Virol. 2010, 82:806-811.
22. Deuzing I., Fagrouch Z., Gronewoud M.J., Niphuis H., Kondova I., Bogers W., Verschoor E.J. Detection and characterization of two chimpanzee polyomavirus genotypes from different subspecies. Virol. J. 2010, 7:347.
23. De Simone V., La Mantia G., Lania L., Amati P. Polyomavirus mutation that confers a cell-specific cis advantage for viral DNA replication. Mol. Cell. Biol. 1985, 5:2142-2146.
24. Doorbar J. The papillomavirus life cycle. J. Clin. Virol. 2005, 32:S7-S15.
25. Endo S., Okada Y., Orba Y., Nishihara H., Tanaka S., Nagashima K., Sawa H. JC virus agnoprotein colocalizes with tubulin. J. Neurovirol. 2003, 9:10-14.
26. Essbauer S., Ahne W. Viruses of lower vertebrates. J. Vet. Med. B 2001, 48:403-475.
27. Fagrouch Z., Karremans K., Deuzing I., van Gessel S., Niphuis H., Bogers W., Verschoor E.J. Molecular analysis of a novel simian virus 40 (SV40) type in rhesus macaques and evidence for double infections with the classical SV40 type. J. Clin. Microbiol. 2011, 49:1280-1286.
28. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319:1096-1100.
29. Fiers W., Contreas R., Haegemann G., Rogiers R., Van de Voorde A., Van Heuverswyn H., Van Herreweghe J., Volckaert G., Ysebaert M. Complete nucleotide sequence of SV40 DNA. Nature 1978, 273:113-120.
30. Fu S.C., Imai K., Horton P. Prediction of leucine-rich nuclear export signal containing proteins with NESsential. Nucleic Acids Res. 2011, 39:e111.
31. Frisque R.J., Bream G.L., Cannella M.T. Human polyomavirus JC virus genome. J. Virol. 1984, 51:458-469.
32. Garibal J., Hollville E., Bell A.I., Kelly G.L., Renouf B., Kawaguchi Y., Rickinson A.B., Wiels J. Truncated form of the Epstein. Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A. J. Virol. 2007, 81:7598-7607.
33. Gardner S.D., Field A.M., Coleman D.V., Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971, 1:1253-1257.
34. Gaynor, A.M., Nissen, M.D., Whiley, D.M., Mackay, I.M., Lambert, S.B., Wu, G., Brennan, D.C., Storch, G.A., Sloots, T.P., Wang, D., 2007. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog. 3, e64.
35. Geballe A.P., Sachs M.S. Translational control by upstream open reading frames. Translational Control of Gene Expression 2000, 595-614. Cold Spring Harbor Laboratory Press, New York. J.W. Hershey, M.B. Mathews (Eds.).
36. Georgopoulou U., Tsitoura P., Kalamvoki M., Mavromara.P. The protein phosphatase 2A represents a novel cellular target for hepatitis C virus NS5A protein. Biochimie 2006, 88:651-662.
37. Gjoerup O., Chang Y. Update on human polyomaviruses and cancer. Adv. Cancer Res. 2010, 106:1-51.
38. Godet A.N., Guergnon J., Croset A., Cayla X., Falanga P.B., Colle J.H., Garcia A. PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins. PLoS One 2010, 5:e13760.
39. Gonzalez M.E., Carrasco L. Viroporins. FEBS Lett. 2003, 552:28-34.
40. Groenewoud M.J., Fagrouch Z., van Gessel S., Niphuis H., Bulavaite A., Warren K.S., Heeney J.L., Verschoor E.J. Characterization of novel polyomaviruses from Bornean and Sumatran orang-utans. J. Gen. Virol. 2010, 91:653-658.
41. Gross L. A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc. Soc. Exp. Biol. Med. 1953, 83:414-421.
42. Halami M.Y., Dorrestein G.M., Couteel P., Heckel G., Muller H., Johne R. Whole genome characterization of a novel polyomavirus detected in fatally diseased canary birds. J. Gen. Virol. 2010, 91:3016-3022.
43. Henkel J.R., Gibson G.A., Poland P.A., Ellis M.A., Hughey R.P., Weisz O.A. Influenza M2 protein channel activity selectively inhibits trans-Golgi network release of apical membrane and secreted proteins in polarized Madin-Darby canine kidney cells. J. Cell. Biol. 2000, 148:495-504.
44. Hirsch H.H., Steiger J. Polyomavirus BK. Lancet Infect. Dis. 2003, 3:611-623.
45. Hong S., Wang L.C., Gao X., Kuo Y.L., Liu B., Merling R., Kung H.J., Shih H.M., Giam C.Z. Heptad repeats regulate protein phosphatase 2a recruitment to I-kappaB kinase gamma/NF-kappaB essential modulator and are targeted by human T-lymphotropic virus type 1 tax. J Biol. Chem. 2007, 282:12119-12126.
46. Hunter T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol. Cell 2007, 28:730-738.
47. Imperiale M.J., Major E.O. Polyomaviruses. Fields Virology 2007, 2263-2298. Lippincott Williams and Wilkins, Philadelphia. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.).
48. Jackson V., Chalkley R. Use of whole-cell fixation to visualize replicating and maturating simian virus 40: identification of new viral gene product. Proc. Nat. Acad. Sci. U.S.A. 1981, 78:6081-6085.
49. Jay G., Nomura S., Anderson C.W., Khoury G. Identification of the SV40 agnogene product: a DNA binding protein. Nature 1981, 291:346-349.
50. Johannessen M., Myhre M.R., Dragset M., Tümmler C., Moens U. Phosphorylation of human polyomavirus BK agnoprotein at Ser-11 is mediated by PKC and has an important regulative function. Virology 2008, 379:97-109.
51. Johannessen M., Walquist M., Gerits N., Dragset M., Spang A., Moens U. BKV agnoprotein interacts with a-soluble N-ethylmaleimide-sensitive fusion attachment protein and negatively influences transport of VSVG-EGFP. PLoS One 2011, 6:e24489.
52. Johne R., Müller H. Avian polyomavirus agnoprotein 1a is incorporated into the virus particle as a fourth structural protein, VP4. J. Gen. Virol. 2001, 82:909-918.
53. Johne R., Wittig W., Fernandez-de-Luco D., Hofle U., Müller H. Characterization of two novel polyomaviruses of birds by using multiply primed rolling-circle amplification of their genomes. J. Virol. 2006, 80:3523-3531.
54. Johne R., Buck C.R., Allander T., Atwood W.J., Garcea R.L., Imperiale M.J., Major E.O., Ramqvist T., Norkin L.C. Taxonomical developments in the family Polyomaviridae. Arch. Virol. 2011, 156:1627-1634.
55. Kaniowska D., Kaminski R., Amini S., Radhakrishnan S., Rapppaport J., Johnson E., Khalili K., Del Valle L., Darbinyan A. Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells. J. Virol. 2006, 80:9288-9299.
56. Kean J.M., Rao S., Wang M., Garcea R.L. Seroepidemiology of human polyomaviruses. PLoS Pathog. 2009, 5:e1000363.
57. Khalili K., White M.K., Sawa H., Nagashima K., Safak M. The agnoprotein of polyomaviruses: a multifunctional auxiliary protein. J. Cell. Physiol. 2005, 204:1-7.
58. Kiemer L., Bendtsen J.D., Blom N. Netacet: predicition of N-terminal acetylation sites. Bioinformatics 2005, 21:1269-1270.
59. Lange A., Mills R.E., Lange C.J., Stewart M., Devine S.E., Corbett A.H. Classical nuclear localization signals: definition, function, and interaction with importin α. J. Biol. Chem. 2007, 282:5101-5105.
60. Lee T.Y., Chen S.A., Hung H.Y., Ou Y.Y. Incorporating distant sequence features and radial basis function networks to identify ubiquitin conjugation sites. PLoS One 2011, 6:e17331.
61. Leendertz F.H., Scuda N., Cameron K.N., Kidega T., Zuberbuhler K., Leendertz S.A., Couacy-Hymann E., Boesch C., Calvignac S., Ehlers B. African great apes are naturally infected with polyomaviruses closely related to merkel cell polyomavirus. J. Virol. 2011, 85:916-924.
62. Li A., Xue Y., Jin C., Wang M., Yao X. Prediction of Nepsilom-acetylation on internal lysines implemented in Bayesian Discriminant Method. Biochem. Biophys. Res. Commun. 2006, 350:818-824.
63. Li S., Brignole C., Marcellus R., Thirlwell S., Binda O., McQuoid M.J., Ashby D., Chan H., Zhang Z., Miron M.J., Pallas D.C., Branton P.E. The adenovirus E4orf4 protein induces G2/M arrest and cell death by blocking protein phosphatase 2A activity regulated by the B55 subunit. J. Virol. 2009, 83:8340-8352.
64. Luo C., Bueno M., Kant J., Randhawa P. Biologic diversity of polyomavirus BK genomic sequences: implications for molecular diagnostic laboratories. J. Med. Virol. 2008, 80:1850-1857.
65. Maginnis M.S., Atwood W.J. JC virus: an oncogenic virus in animals and humans? Semin. Cancer Biol 2009, 19:261-269.
66. Mattaj I.W., Englmeier L. Nucleocytoplasmic transport: the soluble phase. Annu. Rev. Biochem. 1998, 67:265-306.
67. Maturana A.D., Fujita T., Kuroda S. Functions of fasciculation and elongation protein zeta-1 (FEZ1) in the brain. Sci. World J. 2010, 10:1646-1654.
68. Mayer M., Dorries K. Nucleotide sequence and genome organization of the murine polyomavirus, Kilham strain. Virology 1991, 181:469-480.
69. Merabova N., Kaminski R., Krynska B., Amini S., Khalili K., Darbinyan A. JCV agnoprotein-induced reduction in CXCL5/LIX secretion by oligodendrocytes is associated with activation of apototic signaling in neurons. J. Cell. Physiol. 2011, Oct 27. [Epub ahead of print]. 10.1002/jcp.23065.
70. Misra V., Dumonceaux T., Dubois J., Willis C., Nadin-Davis S., Severini A., Wandeler A., Lindsay R., Artsob H. Detection of polyoma and corona viruses in bats of Canada. J. Gen. Virol. 2009, 90:2015-2022.
71. Mizutani T., Sayama Y., Nakanishi A., Ochiai H., Sakai K., Wakabayashi K., Tanaka N., Miura E., Oba M., Kurane I., Saijo M., Morikawa S., Ono S. Novel DNA virus isolated from samples showing endothelial cell necrosis in the Japanese eel, Anguilla japonica. Virology 2011, 412:179-187.
72. Moens U., Van Ghelue M., Johannessen M. Oncogenic potentials of the human polyomavirus regulatory proteins. Cell. Mol. Life Sci. 2007, 64:1656-1678.
73. Moens U., Johannessen M., Bárcena-Panero A., Gerits N., Van Ghelue M. Emerging polyomaviruses in the human population. Rev. Infect. 2010, 1:59-93.
74. Moens U., Ludvigsen M., Van Ghelue M. Human polyomaviruses in skin diseases. Pathol. Res. Int. 2011, 2011:123491.
75. Morris D.R., Geballe A.P. Upstream open reading frames as regulators of mRNA translation. Mol. Cell. Biol. 2000, 20:8635-8642.
76. Myhre M.R., Olsen G.H., Gosert R., Hirsch H.H., Rinaldo C.H. Clinical polyomavirus BK variants with agnogene deletion are non-functional but rescued by trans-complementation. Virology 2010, 398:12-20.
77. Nomura S., Khoury G., Jay G. Subcellular localization of the simian virus 40 agnoprotein. J. Virol. 1983, 45:428-433.
78. Okada Y., Endo S., Takahashi H., Sawa H., Umemura T., Nagashima K. Distribution and function of JCV agnoprotein. J. Neurovirol. 2001, 7:302-306.
79. Okada Y., Suzuki T., Sunden Y., Orba Y., Kose S., Imamoto N., Takahashi H., Tanaka S., Hall W.W., Nagashima K., Sawa H. Dissociation of heterochromatin protein 1 from lamin B receptor induced by human polyomavirus agnoprotein: role in nuclear egress of virus particles. EMBO Rep. 2005, 6:453-457.
80. Orba Y., Kobayashi S., Nakamura I., Ishii A., Hang'ombe B.M., Mweene A.S., Thomas Y., Kimura T., Sawa H. Detection and characterization of a novel polyomavirus in wild rodents. J. Gen. Virol. 2011, 92:789-795.
81. Padgett B.L., Walker D.L., ZuRhein G.M., Eckroade R.J., Dessel B.H. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971, 1:1257-1260.
82. Pawlita M., Clad A., zur Hausen H. Complete DNA sequence of lymphotropic papovavirus: prototype of a new species of the polyomavirus genus. Virology 1985, 143:196-211.
83. Pim D., Massimi P., Dilworth S.M., Banks L. Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A. Oncogene 2005, 24:7830-7838.
84. Raghava S., Giorda K.M., Romano F.B., Heuck A.P., Hebert D.N. The SV40 late protein VP4 is a viroporin that forms pores to disrupt membranes for viral release. PLoS Pathog. 2011, 7:e1002116.
85. Ren J., Gao X., Jin C., Zhu M., Wang X., Shaw A., Wen L., Yao X., Xue Y. Systematic study of protein sumoylation: development of a site-specific predictor SUMOsp2.0. Proteomics 2009, 9:3409-3412.
86. Resnick J., Shenk T. Simian virus 40 agnoprotein facilitates normal nuclear location of the major capsid polypeptide and cell-to-cell spread of virus. J. Virol. 1986, 60:1098-1106.
87. Rinaldo C.H., Traavik T., Hey A. The agnogene of the human polyomavirus BK is expressed. J. Virol. 1998, 72:6233-6236.
88. Rott O., Kroger M., Muller H., Hobom G. The genome of budgerigar fledgling disease virus, an avian polyomavirus. Virology 1998, 165:74-86.
89. Safak M., Gallia G.L., Ansari A., Khalili K. Physical and functional interaction between the Y-box binding protein YB-1 and human polyomavirus JC virus large T antigen. J. Virol. 1999, 73:10146-10157.
90. Safak M., Barrucco R., Darbinyan A., Okada Y., Nagashima K., Khalili K. Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J. Virol. 2001, 75:1476-1486.
91. Safak M., Sadowska B., Barrucco R., Khalili K. Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J. Virol. 2002, 76:3828-3838.
92. Saribas, A.S., Arachea, B.T., White, M.K., Viola, E., Safak, M. Human polyomavirus JC small regulatory agnoprotein forms highly stable dimers and oligomers: Implications for their roles in agnoprotein function. Virlogy, 420, 51-65.
93. Sariyer I.K., Akan I., Palermo V., Gordon J., Khalili K., Safak M. Phosphorylation mutants of JC virus agnoprotein are unable to sustain the viral infection cycle. J. Virol. 2006, 80:3893-3903.
94. Sariyer I.K., Khalili K., Safak M. Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small T antigen. Virology 2008, 375:464-479.
95. Sariyer I.K., Saribas A.S., White M.K., Safak M. Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content. Virol. J. 2011, 8:255.
96. Schowalter R.M., Pastrana D.V., Pumphrey K.A., Moyer A.L., Buck C.B. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010, 7:509-515.
97. Schuurman R., Sol C., van der Noordaa J. The complete nucleotide sequence of bovine polyomavirus. J. Gen. Virol. 1990, 71:1723-1735.
98. Scuda N., Hofmann J., Calvignac-Spencer S., Ruprecht K., Liman P., Kühn J., Hengel H., Ehlers B. A novel polyomavirus closely related to the African green monkey-derived lymphotropic polyomavirus. J. Virol. 2011, 85:4586-4590.
99. Sedman S.A., Good P.J., Mertz J.E. Leader-encoded open reading frames modulate both the absolute and relative rates of synthesis of the virion proteins of simian virus 40. J. Virol. 1989, 63:3884-3893.
100. Seif I., Khoury G., Dhar R. The genome of human papovavirus BKV. Cell 1979, 18:963-977.
101. Shao J., Xu D., Tsai S.N., Wang Y., Ngai S.M. Computational identification of protein methylation sites through Bi-profile bayes feature extraction. PLoS One 2009, 4:e4920.
102. Shenk T.E., Carbon J., Berg P. Construction and analysis of viable deletion mutants of simian virus 40. J. Virol. 1976, 18:664-671.
103. Stewart C.L., Roux K.J., Bruke B. Blurring the boundary: the nuclear envelope extends its reach. Science 2007, 318:1408-1412.
104. Stewart S.E., Eddy B.E., Gochenour A.M., Borgese N.G., Grubbs G.E. The Induction of neoplasms with a substance released from mouse tumors by tissue culture. Virology 1957, 3:380-400.
105. Suzuki T., Okada Y., Semba S., Orba Y., Yamanouchi S., Endo S., Tanaka S., Fujita T., Kuroda S., Nagashima K., Sawa H. Identification of FEZ as a protein that interacts with JC virus agnoprotein and microtubules: role of agnoprotein-induced dissociation of FEZ1 from microtubulues in viral propagation. J. Biol. Chem. 2005, 280:24948-24956.
106. Suzuki T., Orba Y., Okada Y., Sunden Y., Kimura T., Tanaka S., Nagashima K., Hall W.W., Sawa H. The human polyoma JC virus agnoprotein acts as a viroporin. PLoS Pathog. 2010, 6:e1000801.
107. Tokarev A., Guatelli J. Misdirection of membrane trafficking by HIV-1 Vpu and Nef: keys to viral virulence and persistence. Cell. Logist. 2011, 1:90-102.
108. Trowbridge P.W., Frisque R.J. Identification of three new JC virus protein generated by alternative splicing of the early viral mRNA. J. Neurovirol. 1995, 1:195-206.
109. Trusch F., Klein M., Finsterbusch T., Kühn J., Hofmann J., Ehlers B. Seroprevalence of the human polyomavirus9 (HPyV9) and cross-reactivity to the African green monkey-derived lymphotropic polyomavirus (LPV). J. Gen. Virol. 2012, Jan 4. [Epub ahead of print].
110. Tung C.W., Ho S.Y. Computational identification of ubiquitination sites from protein sequences. BMC Bioinf. 2008, 9:310.
111. Unterstab G., Gosert R., Leuenberger D., Lorentz P., Rinaldo R.H., Hirsch H.H. The polyomavirus BK agnoprotein co-localizes with lipid droplets. Virology 2010, 399:322-331.
112. van der Meijden E., Janssens R.W.A., Lauber C., Bouwes Bavinck J.N., Gorbalenya A.E., Feltkamp M.C.W. Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog. 2010, 6:e1001024.
113. van der Meijden E., Kazem S., Burgers M.M., Janssens R., Bouwers Bavinck J.N., de Melker H., Feltkamp M.C. Seroprevalence of trichodysplasia spinulosa-associated polyomavirus. Emerg. Infect. Dis. 2011, 17:1355-1363.
114. Van Ghelue, M., Khan, M.T., Ehlers, B., Moens, U. Genome analysis of the new human polyomaviruses. Rev. Med. Virol., in press. http://dx.doi.org/10.1002/rmv.1711.
115. Verschoor E.J., Groenewoud M.J., Fagrouch Z., Kewalapat A., van Gessel S., Kik M.J., Heeney J.L. Molecular characterization of the first polyomavirus from a New World primate: squirrel monkey polyomavirus. J. Gen. Virol. 2008, 89:130-137.
116. Whitmarsh A.J., Davis R.J. Regulation of transcription factor function by phosphorylation. Cell. Mol. Life Sci. 2000, 57:1172-1183.
117. Zerrahn J., Knippschild U., Winkler T., Deppert W. Independent expression of the transforming amino-terminal domain of SV40 large I antigen from an alternatively spliced third SV40 early mRNA. EMBO J. 1993, 12:4739-4746.